Dashboard
Manage Tickers

ADMAADMA BIOLOGICS, INC.

Nasdaq admabiologics.com


$ 9.22 $ 0.19 (2.16 %)    

Friday, 17-May-2024 11:20:26 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 452.13 $ -0.59 (-0.13 %)
DIA $ 398.91 $ -0.21 (-0.05 %)
SPY $ 528.80 $ -0.13 (-0.02 %)
TLT $ 91.66 $ 0.04 (0.04 %)
GLD $ 223.10 $ 0.86 (0.39 %)
$ 9.06
$ 9.02
$ 9.21 x 309
$ 9.24 x 106
$ 8.93 - $ 9.29
$ 3.06 - $ 9.33
2,114,551
na
2.14B
$ 0.63
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-23-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-10-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-24-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-Q
14 03-25-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 03-13-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 03-13-2019 12-31-2018 10-K
23 11-09-2018 09-30-2018 10-Q
24 08-10-2018 06-30-2018 10-Q
25 05-14-2018 03-31-2018 10-Q
26 03-29-2018 12-31-2017 10-K
27 11-03-2017 09-30-2017 10-Q
28 08-11-2017 06-30-2017 10-Q
29 05-12-2017 03-31-2017 10-Q
30 02-24-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-12-2016 06-30-2016 10-Q
33 05-13-2016 03-31-2016 10-Q
34 03-23-2016 12-31-2015 10-K
35 11-10-2015 09-30-2015 10-Q
36 08-11-2015 06-30-2015 10-Q
37 05-12-2015 03-31-2015 10-Q
38 03-09-2015 12-31-2014 10-K
39 11-10-2014 09-30-2014 10-Q
40 08-11-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

raymond-james-maintains-strong-buy-on-adma-biologics-raises-price-target-to-10
Raymond James Maintains Strong Buy on ADMA...
05/10/2024 16:57:38

Raymond James analyst Elliot Wilbur maintains ADMA Biologics (NASDAQ:ADMA) with a Strong Buy and raises the price target fro...

why-diodes-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Diodes Shares Are Trading Lower By Aro...
05/10/2024 16:44:44

cantor-fitzgerald-maintains-overweight-on-adma-biologics-raises-price-target-to-10
Cantor Fitzgerald Maintains Overweight on ...
05/10/2024 15:02:56

Cantor Fitzgerald analyst Kristen Kluska maintains ADMA Biologics (NASDAQ:ADMA) with a Overweight and raises the price targe...

genpact-posts-upbeat-earnings-joins-groupon-natera-funko-cargurus-and-other-big-stocks-moving-higher-on-friday
Genpact Posts Upbeat Earnings, Joins Group...
05/10/2024 14:48:27

adma-biologics-analysts-increase-their-forecasts-after-upbeat-results
ADMA Biologics Analysts Increase Their For...
05/10/2024 12:32:39

hc-wainwright--co-maintains-buy-on-adma-biologics-raises-price-target-to-10
HC Wainwright & Co. Maintains Buy on ADMA ...
05/10/2024 12:08:12

HC Wainwright & Co. analyst Raghuram Selvaraju maintains ADMA Biologics (NASDAQ:ADMA) with a Buy and raises the price ta...

mizuho-maintains-buy-on-adma-biologics-raises-price-target-to-12
Mizuho Maintains Buy on ADMA Biologics, Ra...
05/10/2024 11:58:25

Mizuho analyst Anthony Petrone maintains ADMA Biologics (NASDAQ:ADMA) with a Buy and raises the price target from $10 to $12.

adma-biologics-sees-fy25-revenue-more-than-410m-vs-389875m-est
ADMA Biologics Sees FY25 Revenue More Than...
05/09/2024 21:15:50

adma-biologics-sees-fy24-revenue-more-than-355m-vs-333875m-est
ADMA Biologics Sees FY24 Revenue More Than...
05/09/2024 21:15:40

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
05/09/2024 20:31:07

adma-biologics-q1-2024-gaap-eps-008-beats-005-estimate-sales-81875m-beat-77275m-estimate
ADMA Biologics Q1 2024 GAAP EPS $0.08 Beat...
05/09/2024 20:28:08

ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.05 ...

a-closer-look-at-6-analyst-recommendations-for-adma-biologics
A Closer Look at 6 Analyst Recommendations...
03/26/2024 12:00:32

hc-wainwright--co-reiterates-buy-on-adma-biologics-raises-price-target-to-75
HC Wainwright & Co. Reiterates Buy on ADMA...
03/26/2024 10:24:44

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates ADMA Biologics (NASDAQ:ADMA) with a Buy and raises the price t...

adma-biologics-reports-fda-approvals-of-extended-room-temperature-storage-conditions-for-asceniv--bivigam
ADMA Biologics Reports FDA Approvals Of Ex...
03/11/2024 11:01:14

The room temperature approval applies to all existing ASCENIV and BIVIGAM lots currently in the commercial supply chain as well...

piper-sandler-maintains-buy-on-adma-biologics-raises-price-target-to-10
Piper Sandler Maintains Buy on ADMA Biolog...
03/01/2024 14:40:14

Piper Sandler analyst Anthony Petrone maintains ADMA Biologics (NASDAQ:ADMA) with a Buy and raises the price target from $9 ...

cantor-fitzgerald-maintains-overweight-on-adma-biologics-raises-price-target-to-8
Cantor Fitzgerald Maintains Overweight on ...
02/29/2024 18:51:41

Cantor Fitzgerald analyst Kristen Kluska maintains ADMA Biologics (NASDAQ:ADMA) with a Overweight and raises the price targe...

forecasting-the-future-4-analyst-projections-for-adma-biologics
Forecasting The Future: 4 Analyst Projecti...
02/29/2024 15:01:01

hc-wainwright--co-reiterates-buy-on-adma-biologics-maintains-6-price-target
HC Wainwright & Co. Reiterates Buy on ADMA...
02/29/2024 14:05:50

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates ADMA Biologics (NASDAQ:ADMA) with a Buy and maintains $6 price...

adma-biologics-sees-fy24-and-fy25-total-revenue-above-330m-and-380m-respectively-up-from-prior-guidance-of-320m-and-370m-respectively
ADMA Biologics Sees FY24 And FY25 Total Re...
02/28/2024 21:56:56

recap-adma-biologics-q4-earnings
Recap: ADMA Biologics Q4 Earnings
02/28/2024 21:30:30

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION